Gracili Therapeutics, Inc.

Pharmaceutical company · Research Triangle Park, North Carolina, United States

Gracili Therapeutics, Inc. is a pharmaceutical company headquartered in Research Triangle Park, North Carolina, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $100,000 sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Gracili Therapeutics at a glance

Typepharmaceutical company

HeadquartersResearch Triangle Park, North Carolina, United States

Earliest incorporation on record2019

SEC CIK1806319

What does Gracili Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $100,000 sold (2020).

Frequently asked questions about Gracili Therapeutics

Where is Gracili Therapeutics headquartered?

Gracili Therapeutics, Inc. is headquartered in Research Triangle Park, North Carolina, United States.

What does Gracili Therapeutics do?

Gracili Therapeutics, Inc. is a pharmaceutical company.

When was Gracili Therapeutics founded?

The earliest incorporation on record for Gracili Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

Opus Genetics, Inc.Durham, North Carolina, United States
Polarean, Inc.Durham, North Carolina, United States
T3D Therapeutics, Inc.Durham, North Carolina, United States
Chimerix IncDurham, North Carolina, United States
LadeRx, LLCDurham, North Carolina, United States
BioMarck Pharmaceuticals LtdDurham, North Carolina, United States
G1 Therapeutics, Inc.Durham, North Carolina, United States
Satsuma Pharmaceuticals, Inc.Durham, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences